LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 228 filers reported holding LOXO ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $24,512,000 | -18.0% | 175,000 | 0.0% | 9.15% | +20.3% |
| Q3 2018 | $29,895,000 | -1.5% | 175,000 | 0.0% | 7.61% | -3.2% |
| Q2 2018 | $30,359,000 | +46.7% | 175,000 | -2.5% | 7.86% | +32.8% |
| Q1 2018 | $20,697,000 | +39.5% | 179,400 | +1.8% | 5.92% | +24.5% |
| Q4 2017 | $14,841,000 | +23.9% | 176,300 | +35.6% | 4.75% | +12.2% |
| Q3 2017 | $11,975,000 | +14.9% | 130,000 | 0.0% | 4.24% | -2.8% |
| Q2 2017 | $10,425,000 | +90.6% | 130,000 | 0.0% | 4.36% | +60.0% |
| Q1 2017 | $5,470,000 | +36.3% | 130,000 | +4.0% | 2.72% | +15.1% |
| Q4 2016 | $4,014,000 | +39.4% | 125,000 | +13.6% | 2.36% | +56.9% |
| Q3 2016 | $2,880,000 | – | 110,000 | – | 1.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |